Health Care • Hospital/Nursing Management
$12.30 ▲ +0.37
(+3.10%)
MKT CAP: $1.73B • VOL: 602.6K
52W L $8 52W H $15
ROARABLE / RQD
C+ • 67/100
PIOTROSKI
7 / 9
ARDT // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $6.32B | $5.97B | $5.41B |
| YoY Revenue Growth % | +6.0% | +10.3% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $0 | $0 | $0 |
| Operating Margin % | — | — | — |
| Net Income (GAAP) | $135.8M | $210.3M | $53.9M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $470.5M | $315.0M | $221.7M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | $470.5M | $315.0M | $221.7M |
| FCF Margin % | 7.4% | 5.3% | 4.1% |
| Return on Invested Capital (ROIC %) | — | — | — |
| Cash & Short-Term Equivalents | $709.6M | $556.8M | — |
| Total Debt (Short + Long Term) | $1.08B | $1.09B | — |
| Total Stockholders' Equity | $1.29B | $1.13B | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR ARDT.